AGP Picks
View all

Advertising Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Advertising Today.

Press releases published on September 3, 2026

Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism
L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.
LB Pharmaceuticals to Participate in Upcoming September Investor Events
Agomab to Participate in Upcoming Investor Conferences
CapsoVision to Participate in Upcoming Investor Conferences
Immuneering to Participate in Upcoming Investor Conferences
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Spyre Therapeutics to Participate in Upcoming September Investor Conferences
Mama’s Creations Reports Second Quarter Fiscal 2027 Financial Results
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Lifecore Biomedical to Participate at CPHI Global Conference
Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference
XPO Provides North American LTL Operating Data for August 2026
Navitas to Present at the Citi Global TMT Conference on September 8, 2026
Attovia Therapeutics to Participate in Upcoming Investor Conferences
Alector to Participate in Upcoming Healthcare Conferences
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
 Xenon to Present at Wells Fargo Healthcare Conference
Arvinas to Participate in Upcoming Investor Conferences
Rein Therapeutics to Present at Upcoming September Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Advertising Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.